Advanced Vision Technologies, Inc.
Developing a novel gene therapy that treats glaucomatous IOP elevation in order to provide an effective treatment option for OAG that will enable treatment independent of the underlying etiology of disease.
Medicon Pharmaceuticals Inc.
A drug development company focusing on novel agents for cancer, inflammation, and dermatological diseases.
Chronus Pharmacuticals, Inc.
Creating superior disease diagnostics and drug candidates with improved efficacy.